Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PF-06688992 |
Synonyms | |
Therapy Description |
PF-06688992 is an antibody drug conjugate consisting of a monoclonal antibody to ganglioside GD3 and a chemotherapeutic agent (NCI Drug Dictionary) |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PF-06688992 | PF06688992|PF 06688992 | PF-06688992 is an antibody drug conjugate consisting of a monoclonal antibody to ganglioside GD3 and a chemotherapeutic agent (NCI Drug Dictionary) |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03159117 | Phase I | PF-06688992 | Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma | Completed | USA | 0 |